Stay updated on Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.

Latest updates to the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe history log now includes a new revision label v3.6.6, replacing the previous v3.6.5. This reflects an update to the page's revision in the study record history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new page revision label 'Revision: v3.6.5' is added to the history, replacing the previous 'Revision: v3.6.4'. This indicates a minor frontend update to the record page without changes to study data or results.SummaryDifference0.2%

- Check42 days agoChange DetectedA new revision (v3.6.4) was added to the study record history, and the previous revision (v3.6.3) was removed from the list, reflecting an update to the record's version history.SummaryDifference0.1%

- Check63 days agoChange DetectedThe record history now includes a newer revision (v3.6.3) replacing the previous revision (v3.6.2), indicating an update to the study record.SummaryDifference0.1%

- Check70 days agoChange DetectedFooter area expanded with additional site-wide links and policy text, representing a system-wide footer update rather than changes to the study content.SummaryDifference31%

- Check77 days agoChange DetectedThe study record history now shows two Results Submission Events instead of one, indicating an additional results submission event reflected in the history.SummaryDifference0.1%

Stay in the know with updates to Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.